Removal Of Black Triangle Status For Crestor, UK

June 22nd, 2007 | Category: Cholesterol

Following a comprehensive analysis of the pre and post marketing details by the Medicines and Healthcare products Regulatory Agency (MHRA) and the Commission on Human Medicines (CHM) the risk/benefit profile for rosuvastatin

(CRESTOR) has been confirmed and black triangle status has been removed for rosuvastatin. [click link for full article]

Original post by Women’s Health / Gynecology News From Medical News Today

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.
  • Digg
  • del.icio.us
  • Netvouz
  • DZone
  • ThisNext
  • MisterWong
  • Wists
  • BlinkList
  • Furl
  • IndianPad
  • Netscape
  • Reddit
  • Simpy
  • Spurl
  • StumbleUpon
  • Technorati
Related Articles
  • Breast Cancer Treatment Disparities amoung Black, White Women In Georgia Exist Despite Health Insurance Status, Study Finds
  • INEGY better than Crestor™ in Achieving Multiple “Goals” for LDL-Cholesterol & Other CHD Risk Factors in Hypercholesterolemia Patients
  • Public Awareness Of Risks Of Black Cohosh Needed, Australian Medical Association
  • Public Awareness Of Risks Of Black Cohosh Needed, Australian Medical Association
  • Black Tea And Diabetes

    • No comments yet. Be the first.

    Leave a reply

    You must be logged in to post a comment.